ENTA Competitors & Alternatives
Compare Enanta Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ENTA
Main Stock$13.47
Tradestie Score
51
Market Cap
$226.82M
Revenue Growth
-0.2%
Analyst Upside
+57.1%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ALMS
Alumis Inc. Common Stock
|
$24.17
|
$422.50M | - | 57 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$77.42
|
$410.79M | - | 46 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$15.83
|
$407.71M | - | 34 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$14.99
|
$386.68M | - | 33 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.80
|
$382.04M | - | 47 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$14.92
|
$371.64M | - | 38 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$21.68
|
$354.45M | - | 31 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$47.62
|
$353.70M | - | 42 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.61
|
$350.98M | - | 53 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.11
|
$341.56M | - | 42 | Compare |
More ENTA Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
238 stocks in this industry